Electromed, Inc.
500 6th Ave NW
New Prague
Minnesota
56071
United States
Tel: 800-462-1045 or 952-758-9299
Fax: 866-758-5077
Website: http://www.electromed.com/info_pages/elect...
Email: info@electromed.com
132 articles about Electromed, Inc.
-
Electromed, Inc. Announces Fiscal 2021 Third Quarter Financial Results
5/11/2021
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced its financial results for the three months ended March 31, 2021 (“Q3 FY 2021”).
-
Electromed, Inc. Schedules its Third Quarter Fiscal 2021 Financial Results Conference Call for May 11, 2021 at 5:00 p.m. ET
4/27/2021
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2021 third quarter ended March 31, 2021
-
Electromed, Inc. to Participate in the Sidoti Spring 2021 Virtual Investor Conference
3/4/2021
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Mike MacCourt, Chief Financial Officer, are scheduled to participate in the Sidoti Spring 2021 Virtual Investor Conference on March 24-25, 2021.
-
Electromed, Inc. Announces Fiscal 2021 Second Quarter Financial Results
2/9/2021
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended December 31, 2020 (“Q2 FY 2021”).
-
Electromed, Inc. Schedules its Second Quarter Fiscal 2021 Financial Results Conference Call for February 9, 2021 at 5:00 p.m. ET
1/26/2021
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2021 second quarter ended December 31, 2020 on Tuesday, February 9, 2021 after the close of the stock market and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results.
-
Andrea M. Walsh Elected to Electromed, Inc. Board of Directors
11/18/2020
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that its shareholders have elected Andrea M. Walsh to serve as an additional director of the Company.
-
Electromed, Inc. Schedules its First Quarter Fiscal 2021 Financial Results Conference Call for November 10, 2020 at 5:00 p.m. ET
10/27/2020
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2021 first quarter ended September 30, 2020 on Tuesday, November 10, 2020 after the close of the stock market and host a conference call the same day at 5:00 p.m. Eastern Time
-
Electromed, Inc. to Participate in the 2020 Colliers Institutional Investor Conference
8/26/2020
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Mike MacCourt, Chief Financial Officer, are scheduled to participate in the 2020 Colliers Institutional Investor Conference, which will be held virtually, on Thursday, September 10, 2020. About Electromed, In
-
Electromed, Inc. Announces Fiscal 2020 Fourth Quarter and Full Year Financial Results
8/25/2020
-- Record profitability: diluted EPS of $0.47 in fiscal 2020 versus $0.23 in fiscal 2019 --
-
Electromed, Inc. Set to Join Russell 3000® Index
6/8/2020
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that the Company is set to join the broad-market Russell 3000® Index at the conclusion of the 2020 Russell indexes annual reconstitution, effective after the US market opens on June 29, according to a preliminary list of additions posted June 5, 2020.
-
Electromed, Inc. Appoints Michael J. MacCourt as Chief Financial Officer
5/18/2020
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that its Board of Directors has appointed Michael J. MacCourt as the Company’s Chief Financial Officer, effective May 26, 2020.
-
Electromed, Inc. Announces Fiscal 2020 Third Quarter Financial Results
5/12/2020
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended March 31, 2020 (“Q3 FY 2020”).
-
Electromed, Inc. Schedules its Third Quarter Fiscal 2020 Financial Results Conference Call for May 13, 2020 at 8:30 a.m. ET
4/29/2020
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2020 third quarter ended March 31, 2020 on Tuesday, May 12, 2020 after the close of the stock market.
-
Electromed, Inc. Launches SmartVest Connect Mobile Application
3/10/2020
Electromed, Inc. (NYSE American: ELMD) today announced the launch of its SmartVest Connect ® App for iOS and Android, a personalized high frequency chest wall oscillation (HFCWO) therapy management portal for patients with compromised pulmonary function. The SmartVest Connect app securely connects to the SmartVest ® SQL ® through Bluetooth™ technology. This interface allows patients and healthcare teams to track th
-
Electromed, Inc. Announces CFO Transition
3/4/2020
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that CFO Jeremy Brock has elected to pursue other opportunities and the Company and Mr. Brock have established a transition plan.
-
Electromed, Inc. Announces Fiscal 2020 Second Quarter Financial Results
2/11/2020
Net income of $1.2 million driven by 6.7% revenue growth from prior year period and 18.3% operating margin
-
Electromed, Inc. Schedules its Second Quarter Fiscal 2020 Financial Results Conference Call for February 12, 2020 at 8:30 a.m. ET
1/29/2020
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2020 second quarter ended December 31, 2019 on Tuesday, February 11, 2020 after the close of the stock market.
-
Electromed, Inc. Schedules Release of First Quarter Fiscal 2020 Financial Results and Conference Call
10/30/2019
Electromed, Inc., a leader in innovative airway clearance technologies, announced that it will issue its financial results press release for the fiscal 2020 first quarter ended September 30, 2019 on Tuesday, November 12, 2019 after the close of the stock market.
-
Electromed, Inc. To Participate in the Sidoti & Company Fall 2019 Investor Conference
9/10/2019
Electromed, Inc. (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that management will participate in the Sidoti & Company Fall 2019 Investor Conference in New York, NY on Wednesday, September 25, 2019.
-
Electromed, Inc. Announces Fiscal 2019 Fourth Quarter and Full Year Financial Results
8/27/2019
Fourth quarter results driven by 10.1% year-over-year growth in home care revenue and operating margin improvement to 17.3%